Product Image

Huperzine A 250 mcg

California Gold Nutrition
4.7
★ ★ ★ ★ ★
(2453 ratings)
Huperzine 250 mcg
Product Image
Score83
Clear sourcing cannot fully offset a high, inflexible Huperzine A serving. It may suit experienced users seeking occasional targeted support, but frequent use raises practical concerns.
How scoring works
Quantity:90 Capsule(s) • (90 servings)
Goals:
Brain Health
Productivity Boost
Mental Focus
Cognitive Support

Score 83

Clear sourcing cannot fully offset a high, inflexible Huperzine A serving. It may suit experienced users seeking occasional targeted support, but frequent use raises practical concerns.
How scoring works

Also available as

1 option
$17.82($0.19 per serving)
iHerb
$ 17.82
Report prices

Analysis

Huperzine A directly affects acetylcholine signaling and may temporarily support attention and memory. The toothed clubmoss source and exact 250 mcg active amount are both disclosed.

The serving is higher than many users need and offers little room for a cautious starting approach. Evidence for routine cognitive enhancement in healthy adults is also less certain than the ingredient's potent mechanism suggests.

No cycling guidance addresses the long duration of action, which can allow cholinergic effects to build with frequent use. The formula also lacks ingredients for mental energy, stress resilience, circulation, or structural brain nutrition.

Who is it for
  • Experienced users who specifically want high-potency Huperzine A
  • People seeking occasional single-pathway cognitive support
Best for
  • Clearly sourced high-potency Huperzine A
  • Users already familiar with their tolerance

Pros

  • Identifies toothed clubmoss as the source
  • Discloses the exact active amount
  • Focused formula contains no unrelated actives

Cons

  • Serving is higher than many users need
  • No cycling guidance is supplied
  • Provides narrow rather than broad cognitive support

Warnings

  • The 250 mcg amount may increase nausea, dizziness, vivid dreams, muscle twitching, or a slowed heart rate in sensitive users.
  • Frequent dosing can allow cholinergic effects to accumulate because Huperzine A is long acting.
  • Combining it with acetylcholinesterase inhibitors or other cholinergic medicines may intensify their effects.

Nutrient quality

85 Highest impact

A precise huperzine A amount from a named botanical source supports strong form quality. The high amount and missing cycling guidance create a meaningful accumulation concern.

.

Ingredient transparency

83 Highest impact

The active amount and botanical source are disclosed without a hidden blend. Cycling guidance, complete directions, and inactive ingredients are not supplied.

.

Customer satisfaction

71 High impact

The supplied average rating is strong. A very large rating base makes the average dependable, but no detailed experience evidence was supplied.

.

Value for money

92 Highest impact

Serving economics are highly favorable. Formula quality supports the asking price well.

.
Report analysis

Goals

Brain Health
Impact
High effect
A- Goal FitC+ Strength of SupportD CoverageA Formula Quality
Huperzine · 250 mcg

Huperzine A directly increases acetylcholine signaling and is closely aligned with short-term memory support. It is a potent acute nootropic rather than foundational daily brain nutrition.

The 250 mcg amount is higher than many users need despite precise disclosure and a clear clubmoss source. Frequent use may cause accumulation and cholinergic effects such as nausea or slow heart rate because huperzine A remains active for an extended period.

Study evidence
Huperzine Supportive 17 studies
Productivity Boost
Impact
High effect
B- Goal FitB- Strength of SupportC- CoverageA Formula Quality
Huperzine · 250 mcg

Huperzine A can raise acetylcholine activity and may support memory and concentrated task work. Evidence for routine productivity use in healthy adults remains limited compared with established stimulants.

The active source and exact amount are clear, but the serving is higher than usually needed for many users. Its long action makes frequent use more likely to accumulate, so repeated daily dosing may increase nausea, sleep disturbance, or other cholinergic effects.

Study evidence
Huperzine No effect 1 study
Mental Focus
Impact
High effect
B+ Goal FitC+ Strength of SupportD- CoverageA Formula Quality
Huperzine · 250 mcg

Huperzine A directly raises acetylcholine signaling by slowing its breakdown, which may sharpen attention and memory. Human evidence for routine use in healthy adults remains less certain than its potent mechanism suggests.

The exact source and amount are clear, but the serving is higher than commonly needed and the label provides no cycling guidance. Its long action and cholinergic effects may cause nausea, vivid dreams, slowed heart rate, or excessive effects when combined with cholinesterase-inhibiting medicines.

Study evidence
Huperzine Not classified

No linked studies yet.

Cognitive Support
Impact
High effect
B+ Goal FitB- Strength of SupportD- CoverageB Formula Quality
Huperzine · 250 mcg

Huperzine A directly slows acetylcholine breakdown and may temporarily support attention and memory. Its role is acute and narrow rather than foundational for long-term brain health.

The source and exact 250 mcg amount are clear, but the serving is higher than many people need and no cycling guidance is provided. Accumulation may cause nausea, dizziness, slow heart rate, vivid dreams, or other cholinergic effects, especially with cholinergic or anticholinergic medicines.

Study evidence
Huperzine Supportive 22 studies

Ingredients

IngredientAmount per serving
Huperzine A (Toothed Clubmoss Whole Plant Extract)
250 mcg
Gluten Free Adults 18–50 Dairy Free No Allergies
Report overview
A+ Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyA+ Value

The capsule offers precise delivery and clearly identifies Huperzine A from Toothed Clubmoss extract. Its active amount is higher than usually needed for most users, even though the cost efficiency is strong. The high serving amount and lack of cycling guidance raise a practical accumulation concern with frequent use.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. A phase II trial of huperzine A in mild to moderate Alzheimer disease.
    Rafii MS; Walsh S; Little JT; Behan K; Reynolds B; Ward C; Jin S; Thomas R; Aisen PS; Alzheimer's Disease Cooperative Study · Neurology · 2011
    Randomized trial210 participantsCognitive Support forHuperzine
  2. Huperzine A for vascular dementia.
    Hao Z; Liu M; Liu Z; Lv D · The Cochrane database of systematic reviews · 2009
    Systematic review14 participants1 studies pooledCognitive Support forHuperzine
  3. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT · Human psychopharmacology · 2017
    Meta-analysis1,117 participants12 studies pooledCognitive Support forHuperzine
  4. Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
    Xing SH; Zhu CX; Zhang R; An L · Evidence-based complementary and alternative medicine : eCAM · 2014
    Meta-analysis825 participants10 studies pooledCognitive Support Brain Health forHuperzine
  5. Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
    Zhang Z; Shen Y; Li J; Tang Y; Zhou P; Ying T; Mo R; Ru Z; Zhao G; Zhu J; Li S; Zhao H · International journal of surgery (London, England) · 2026
    Randomized trial123 participantsCognitive Support Brain Health forHuperzine
  6. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
    Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G · Zhonghua yi xue za zhi · 2002
    Randomized trial202 participantsCognitive Support Brain Health forHuperzine
  7. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis.
    Wang BS; Wang H; Wei ZH; Song YY; Zhang L; Chen HZ · Journal of neural transmission (Vienna, Austria : 1996) · 2009
    Meta-analysis4 studies pooledCognitive Support forHuperzine
  8. Huperzine A for Alzheimer's disease.
    Li J; Wu HM; Zhou RL; Liu GJ; Dong BR · The Cochrane database of systematic reviews · 2008
    Meta-analysis454 participants6 studies pooledCognitive Support forHuperzine
  9. The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis.
    Perng CH; Chang YC; Tzang RF · Psychopharmacology · 2019
    Meta-analysis44,854 participants235 studies pooledCognitive Support forHuperzine
  10. The effect of anti-dementia drugs on Alzheimer disease-induced cognitive impairment: A network meta-analysis.
    Cui CC; Sun Y; Wang XY; Zhang Y; Xing Y · Medicine · 2019
    Meta-analysis33 studies pooledCognitive Support forHuperzine
  11. Treatment with Huperzine A improves cognition in vascular dementia patients.
    Xu ZQ; Liang XM; Juan-Wu; Zhang YF; Zhu CX; Jiang XJ · Cell biochemistry and biophysics · 2012
    Randomized trial78 participantsBrain Health forHuperzine
  12. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
    Gul A; Bakht J; Mehmood F · Journal of the Chinese Medical Association : JCMA · 2019
    Randomized trial100 participantsBrain Health forHuperzine
  13. [Drug evaluation of huperzine A in the treatment of senile memory disorders].
    Zhang RW; Tang XC; Han YY; Sang GW; Zhang YD; Ma YX; Zhang CL; Yang RM · Zhongguo yao li xue bao = Acta pharmacologica Sinica · 1992
    Randomized trial56 participantsCognitive Support forHuperzine
  14. Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.
    Wessinger CM; Inman CL; Weinstock J; Weiss EP · International journal of exercise science · 2025
    Randomized trial15 participantsProductivity Boost forHuperzine